|
|
乳腺癌患者心房颤动发病危险因素分析
|
Abstract:
目的：探讨乳腺癌患者心房颤动发病的危险因素。方法：回顾性收集2022年1月至2022年12月确诊为乳腺癌的患者342例临床资料，根据心电图诊断依据分为心房颤动组与窦性心律组，采用卡方检验对分类变量危险因素进行分析，采用logistic回归模型对连续变量危险因素进行分析。结果：年龄、HER-2阳性、Ki-67阴性、低镁血症与乳腺癌患者房颤的发生存在密切关联。
Objective: To explore the risk factors for atrial fibrillation onset in breast cancer patients. Methods: Clinical data of 342 patients diagnosed with breast cancer from January 2022 to December 2022 were retrospectively collected. Patients were divided into atrial fibrillation group and sinus rhythm group based on electrocardiogram diagnosis. Chi-square test was used to analyze categorical variable risk factors, and logistic regression model was used to analyze continuous variable risk factors. Results: Age, HER-2 positivity, Ki-67 negativity and hypomagnesemia were closely associated with the occurrence of atrial fibrillation in breast cancer patients.
| [1] | Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. Ca-A Cancer Journal for Clinicians, 73, 17-48. https://doi.org/10.3322/caac.21763 |
| [2] | Huang, J., Chan, P.S., Lok, V., Chen, X., Ding, H., Jin, Y., Yuan, J., Lao, X.Q., Zheng, Z.J. and Wong, M.C. (2021) Global Incidence and Mortality of Breast Cancer: A Trend Analysis. Aging (Albany NY), 13, 5748-5803. https://doi.org/10.18632/aging.202502 |
| [3] | Galimzhanov, A., Istanbuly, S., Tun, H.N., Ozbay, B., Alasnag, M., Ky, B., Lyon, A.R., Kayikcioglu, M., Tenekecioglu, E., Panagioti, M., et al. (2023) Cardiovascular Outcomes in Breast Cancer Survivors: A Systematic Review and Meta-Analysis. European Journal of Preventive Cardiology, 30, 2018-2031. https://doi.org/10.1093/eurjpc/zwad243 |
| [4] | Yang, H., Bhoo-Pathy, N., Brand, J.S., Hedayati, E., Grassmann, F., Zeng, E., Bergh, J., Bian, W., Ludvigsson, J.F., Hall, P., et al. (2022) Risk of Heart Disease Following Treatment for Breast Cancer: Results from a Population-Based Cohort Study. Elife, 11, e71562. https://doi.org/10.7554/eLife.71562.sa2 |
| [5] | Zimetbaum, P. (2017) Atrial Fibrillation. Annals of Internal Medicine, 166, ITC33-ITC48. https://doi.org/10.7326/AITC201703070 |
| [6] | Jakobsen, C.B., Lamberts, M., Carlson, N., Lock-Hansen, M., Torp-Pedersen, C., Gislason, G.H. and Schou, M. (2019) Incidence of Atrial Fibrillation in Different Major Cancer Subtypes: A Nationwide Population-Based 12 Year Follow Up Study. BMC Cancer, 19, 1105. https://doi.org/10.1186/s12885-019-6314-9 |
| [7] | Higuchi, S., Kabeya, Y., Matsushita, K., Arai, N., Tachibana, K., Tanaka, R., Kawachi, R., Takei, H., Suzuki, Y., Kogure, M., et al. (2019) Incidence and Complications of Perioperative Atrial Fibrillation after Non-Cardiac Surgery for Malignancy. PLOS ONE, 14, E0216239. https://doi.org/10.1371/journal.pone.0216239 |
| [8] | Abdel-Qadir, H., Thavendiranathan, P., Fung, K., Amir, E., Austin, P.C., Anderson, G.S. and Lee, D.S. (2019) Association of Early-Stage Breast Cancer and Subsequent Chemotherapy with Risk of Atrial Fibrillation. JAMA Network Open, 2, E1911838. https://doi.org/10.1001/jamanetworkopen.2019.11838 |
| [9] | Beck, R.E., Kim, L., Yue, N.J., Haffty, B.G., Khan, A.J. and Goyal, S. (2014) Treatment Techniques to Reduce Cardiac Irradiation for Breast Cancer Patients Treated with Breast-Conserving Surgery and Radiation Therapy: A Review. Frontiers in Oncology, 4, 327. https://doi.org/10.3389/fonc.2014.00327 |
| [10] | Guha, A., Fradley, M.G., Dent, S.F., Weintraub, N.L., Lustberg, M.B., Alonso, A. and Addison, D. (2022) Incidence, Risk Factors, and Mortality of Atrial Fibrillation in Breast Cancer: A Seer-Medicare Analysis. European Heart Journal, 43, 300-312. https://doi.org/10.1093/eurheartj/ehab745 |
| [11] | Shalapour, S. and Karin, M. (2019) Pas De Deux: Control of Anti-Tumor Immunity by Cancer-Associated Inflammation. Immunity, 51, 15-26. https://doi.org/10.1016/j.immuni.2019.06.021 |
| [12] | Aviles, R.J., Martin, D.O., Apperson-Hansen, C., Houghtaling, P.L., Rautaharju, P., Kronmal, R.A., Tracy, R.P., Van Wagoner, D.R., Psaty, B.M., Lauer, M.S., et al. (2003) Inflammation as a Risk Factor for Atrial Fibrillation. Circulation, 108, 3006-3010. https://doi.org/10.1161/01.CIR.0000103131.70301.4F |
| [13] | Andersson, T.M., Rutherford, M.J. and Humphreys, K. (2017) Assessment of Lead-Time Bias in Estimates of Relative Survival for Breast Cancer. Cancer Epidemiology, 46, 50-56. https://doi.org/10.1016/j.canep.2016.12.004 |
| [14] | Moturi, S., Rao, S.N.T. and Vemuru, S. (2021) Grey Wolf Assisted Dragonfly-Based Weighted Rule Generation for Predicting Heart Disease and Breast Cancer. Computerized Medical Imaging and Graphics, 91, Article ID 101936. https://doi.org/10.1016/j.compmedimag.2021.101936 |
| [15] | Linz, D., Gawalko, M., Betz, K., Hendriks, J.M., Lip, G.Y.H., Vinter, N., Guo, Y. and Johnsen, S. (2024) Atrial Fibrillation: Epidemiology, Screening and Digital Health. The Lancet Regional Health-Europe, 37, Article ID 100786. https://doi.org/10.1016/j.lanepe.2023.100786 |
| [16] | Jame, S. and Barnes, G. (2020) Stroke and Thromboembolism Prevention in Atrial Fibrillation. Heart, 106, 10-17. https://doi.org/10.1136/heartjnl-2019-314898 |
| [17] | Joglar, J.A., Chung, M.K., Armbruster, A.L., Benjamin, E.J., Chyou, J.Y., Cronin, E.M., Deswal, A., Eckhardt, L.L., Goldberger, Z.D., Gopinathannair, R., et al. (2024) 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of The American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149, E1-E156. https://doi.org/10.1161/CIR.0000000000001193 |
| [18] | Beral, V., Banks, E., Reeves, G. and Bull, D. (On Behalf of the Million Women Study Collaborator) (2003) Breast Cancer and Hormone-Replacement Therapy in the Million Women Study. Lancet, 362, 419-427. https://doi.org/10.1016/S0140-6736(03)14596-5 |
| [19] | January, C.T., Wann, L.S., Alpert, J.S., Calkins, H., Cigarroa, J.E., Cleveland Jr., J.C., Conti, J.B., Ellinor, P.T., Ezekowitz, M.D., Field, M.E., et al. (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: Executive Summary: A Report of The American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Heart Rhythm Society. Circulation, 130, 2071-2104. https://doi.org/10.1161/CIR.0000000000000040 |
| [20] | Nalliah, C.J., Bell, J.R., Raaijmakers, A.J.A., Waddell, H.M., Wells, S.P., Bernasochi, G.B., Montgomery, M.K., Binny, S., Watts, T., Joshi, S.B., et al. (2020) Epicardial Adipose Tissue Accumulation Confers Atrial Conduction Abnormality. Journal of the American College of Cardiology, 76, 1197-1211. https://doi.org/10.1016/j.jacc.2020.07.017 |
| [21] | Venteclef, N., Guglielmi, V., Balse, E., Gaborit, B., Cotillard, A., Atassi, F., Amour, J., Leprince, P., Dutour, A., Clement, K., et al. (2015) Human Epicardial Adipose Tissue Induces Fibrosis of the Atrial Myocardium through the Secretion of Adipo-Fibrokines. European Heart Journal, 36, 795-805. https://doi.org/10.1093/eurheartj/eht099 |
| [22] | Mazurek, T., Zhang, L., Zalewski, A., Mannion, J.D., Diehl, J.T., Arafat, H., Sarov-Blat, L., O’Brien, S., Keiper, E.A., Johnson, A.G., et al. (2003) Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators. Circulation, 108, 2460-2466. https://doi.org/10.1161/01.CIR.0000099542.57313.C5 |
| [23] | Darby, S.C., Ewertz, M., McGale, P., Bennet, A.M., Blom-Goldman, U., Br？nnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. The New England Journal of Medicine, 368, 987-998. https://doi.org/10.1056/NEJMoa1209825 |
| [24] | Meattini, I., Poortmans, P.M., Aznar, M.C., Becherini, C., Bonzano, E., Cardinale, D., Lenihan, D.J., Marrazzo, L., Curigliano, G. and Livi, L. (2021) Association of Breast Cancer Irradiation with Cardiac Toxic Effects: A Narrative Review. JAMA Oncology, 7, 924-932. https://doi.org/10.1001/jamaoncol.2020.7468 |
